XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.1
Share-based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Compensation
The following table presents total share-based compensation expense within each functional line item on the condensed consolidated statements of operations for the three months ended March 31, 2025 and 2024 (in thousands):
 Three Months Ended
March 31,
  20252024
Cost of revenues$52 $25 
Research and development268 160 
Sales and marketing146 164 
General and administrative1,135 339 
Income from discontinued operations, net of tax— 29 
      Total$1,601 $717 
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity for the three months ended March 31, 2025:
Outstanding — December 31, 2024269,851 
Granted893,000 
Exercised(4,636)
Canceled(36,732)
Outstanding — March 31, 20251,121,483 
Exercisable — March 31, 2025134,598 
Schedule of Stock Options, Valuation Assumptions The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the awards:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)10
Risk-free interest rate4.57 %
Volatility84.00 %
Expected dividend yield— %
The following table details the key assumptions utilized in the Monte Carlo simulation model used to calculate the grant-date fair value of the Market-based CEO RSUs:
January 6, 2025
Valuation date stock price$11.23 
Simulation term (years)3
Risk-free interest rate4.25 %
Volatility105.63 %
Expected dividend yield— %
Correlation coefficient0.3741
Schedule of Restricted Stock Unit Activity
The following table summarizes the Company’s RSU activity for the three months ended March 31, 2025:
Non-vested — December 31, 20241,111,841 
Granted338,776 
Vested(51,534)
Forfeited(81,277)
Non-vested — March 31, 20251,317,806